Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer

PURPOSE: Combination of biological therapy and chemotherapy improves the survival of patients with metastatic colorectal cancer (mCRC). However, the optimal biological therapy sequence remains unclear. In this retrospective study, we evaluated the clinical outcomes of patients with mCRC treated with...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Med
Egile Nagusiak: Hsu, Hung‐Chih, Liu, Yu‐Chun, Wang, Chuang‐Wei, Chou, Wen-Chi, Hsu, Yu-Jen, Chiang, Jy-Ming, Lin, Yung-Chang, Yang, Tsai-Sheng
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2019
Gaiak:
Clinical Cancer Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6601597/
https://ncbi.nlm.nih.gov/pubmed/31090176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2235
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak